C4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Increase in Short Interest
C4 Therapeutics, Inc. (NASDAQ:CCCC Get Free Report) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 5,290,000 shares, a growth of...